Reinglas J, Gonczi L, Verdon C, Bessissow T, et al. Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center. Dig Dis Sci 2020;65:2046-2053.
PMID: 31813132